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Abstract 1 
Objective 2 
Depression is a potential risk factor for developing inflammatory bowel disease (IBD). This 3 
association may be related to gastrointestinal (GI) symptoms occurring before diagnosis. We 4 
aimed to determine whether depression, adjusted for pre-existing GI symptoms, is associated 5 
with subsequent IBD. 6 
Design 7 
We conducted a nested case-control study using the Clinical Practice Research Datalink 8 
identifying incident cases of ulcerative colitis (UC) and Crohn’s Disease (CD) from 1998-2016. 9 
Controls without IBD were matched for age and sex. We measured exposure to prevalent 10 
depression 4.5-5.5 years before IBD diagnosis. We created 2 sub-groups with prevalent 11 
depression based on whether individuals had reported GI symptoms before the onset of 12 
depression. We used conditional logistic regression to derive odds ratios for the risk of IBD 13 
depending on depression status. 14 
Results 15 
We identified 10,829 UC cases, 4,531 CD cases and 15,360 controls.  16 
There was an excess of prevalent depression five years before IBD diagnosis relative to 17 
controls (UC: 3.7% vs 2.7%, CD 3.7% vs 2.9%). 18 
Individuals with GI symptoms prior to the diagnosis of depression had increased adjusted risks 19 
of developing UC and CD compared to those without depression (UC: OR 1.47, 95% CI 1.21-20 
1.79, CD: OR 1.41, 95% CI 1.04-1.92). Individuals with depression alone had similar risks of UC 21 
and CD to those without depression (UC: OR 1.13, 95% CI 0.99-1.29, CD: OR 1.12, 95% CI 0.91-22 
1.38). 23 
Conclusions   24 
Depression, in the absence of prior GI symptoms, is not associated with subsequent 25 
development of IBD. However, depression with GI symptoms should prompt investigation for 26 
IBD. 27 
Abstract Word Count: 250/250 28 
29 
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Summary Box 1 
 2 
What is already known about this subject? 3 
Depression has been associated with a two-fold risk of developing inflammatory bowel diseases 4 
(IBD). However, Individuals often experience gastrointestinal (GI) symptoms for many years before 5 
receiving a diagnosis of IBD. It is unclear whether the apparent association between prior depression 6 
and subsequent IBD potentially represents reverse causation, where undiagnosed symptoms of IBD 7 
result in depression. 8 
What are the new findings? 9 
Individuals with IBD have a higher prevalence of depression than matched controls as early as nine 10 
years before diagnosis. Depression in the absence of prior GI symptoms, is not associated with a future 11 
diagnosis of either UC or CD. However, those with depression diagnosed after already experiencing GI 12 
symptoms are at increased risk of later being diagnosed with UC and CD. The excess prevalence of 13 
depression prior to a diagnosis of IBD may be a consequence of diagnostic delay and untreated GI 14 
symptoms.  15 
How might it impact on clinical practice in the foreseeable future? 16 
Depression in combination with persistent GI symptoms may represent undiagnosed IBD.  NICE and 17 
BSG guidelines recommend the use of the faecal calprotectin test, a non-invasive biomarker of 18 
gastrointestinal inflammation, to evaluate such patients in primary care to determine whether 19 
onward specialist referral is appropriate.  20 
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Introduction 1 
 2 
Patients with Inflammatory Bowel Diseases (IBD), comprising Crohn’s Disease (CD) and ulcerative 3 
colitis (UC), are more likely to be diagnosed with depression in the years following diagnosis.1–3 Studies 4 
of the association between IBD and depression show a bi-directional relationship.4,5  This has led to a 5 
hypothesis that depression is a risk factor for developing IBD and that treating it may reduce this risk.6,7 6 
Possible biological mechanisms for this are that persistent stress manifesting as depression drives a 7 
neuro-enteric pathway through chronic activation of the hypothalamic-pituitary-adrenal axis inducing 8 
systemic pro-inflammatory cytokines, which has been demonstrated in experimental models.8–11 9 
The lifetime risk of depression amongst individuals with IBD is twice that of matched controls.12 10 
Similarly, in the opposite direction, there is a two-fold risk of IBD developing amongst people with 11 
depression.7 The time between onset of gastrointestinal (GI) symptoms and diagnosis of IBD is 12 
frequently prolonged.13 These symptoms, often characterised by pain and changes of bowel habit, 13 
may cause distress and, potentially, depression.  Furthermore, immune-dysregulation and the 14 
inflammatory burden of IBD may be associated with the onset of depression, which can occur in a 15 
range of immune-mediated inflammatory diseases.2,14,15 This indicates the apparent association 16 
between prior depression and subsequent IBD potentially represents reverse causation, whereby 17 
symptoms of IBD result in depression rather than the other way around.16  Previous studies have not 18 
accounted for the ordering of such ‘prodromal’ GI symptoms, common in the years leading up to the 19 
diagnosis of IBD, in relation to the emergence of depression.7,16,17 Thus, it remains uncertain whether 20 
the higher rates of depression prior to IBD diagnosis reflect the effect of symptoms of undiagnosed 21 
IBD.  22 
Using a nationally representative population-based nested case-control study design we aimed to 23 
test the hypothesis that the diagnosis of depression is associated with subsequent onset of IBD after 24 
accounting for prior GI symptoms. 25 
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Methods 1 
 2 
Data source and Ethical approval  3 
We identified cases and controls from a previously defined population-based incident cohort using 4 
the Clinical Practice Research Datalink (CPRD), one of the largest validated primary care research 5 
databases in the world. It contains longitudinal, patient-level, anonymised electronic health records 6 
of 18 million patients from more than 700 general practices and is broadly representative of the United 7 
Kingdom (UK) population.18  Primary care physicians use Read codes to record symptoms, diagnoses 8 
and prescriptions. Data are audited to ensure accuracy and completeness. The database has been 9 
extensively validated and used for research of long term conditions including IBD and depression.19–24 10 
We obtained ethical and scientific approval for our study from the Independent Scientific Advisory 11 
Committee (ISAC Protocol number: 15_018R). 12 
Study Part 1: Depression before the diagnosis of IBD 13 
We conducted a case-control study to determine the prevalence of depression in the 10 years 14 
before the diagnosis of IBD compared to individuals without IBD. 15 
Incident case definition 16 
We defined incident IBD cases as individuals with a first ever diagnosis Read code for either CD or UC 17 
at least one year after registering with an 'Up To Standard' practice for the period January 1st 1998 to 18 
May 1st 2016 using a published and validated methodology by Lewis et al.19 We excluded individuals 19 
if they had records indicating both CD and UC, or indeterminate codes. Cases contributed time to the 20 
study from their date of registration on the database until the date of their IBD diagnosis, which was 21 
used as their index date. 22 
Control Groups 23 
Each case of CD and UC was individually matched on age and sex to four controls without a recorded 24 
diagnosis of either CD or UC at any stage of their follow-up. After stratification by age and sex, the 25 
members of the control groups were selected at random. By definition, members of the control groups 26 
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had no date for a diagnosis of IBD so each was assigned the IBD diagnosis date of their matched IBD 1 
case as their index date.25  2 
Statistical Analysis 3 
Baseline characteristics of the cases and controls were summarised using frequencies and 4 
percentages. We determined the prevalence of depression in the year of IBD diagnosis and each of 5 
the ten years before it. Individuals were included in the denominator for each year examined, 6 
provided their follow-back covered that entire year. We defined prevalent depression as any individual 7 
with a code for a diagnosis or symptoms of depression in that year, or a prescription for antidepressant 8 
medication in that year and a previous code for depression in their clinical record. We estimated the 9 
risk differences (95% CI) of prevalent depression between cases and controls (i.e. the absolute 10 
difference in the prevalence of depression between these two groups).  11 
Study Part 2: Prior depression and the risk of IBD 12 
 13 
We conducted a nested case-control study to determine the risk of IBD based on exposure to 14 
depression 4.5-5.5 years before the index date. 15 
Selection of cases and controls 16 
 17 
We identified all cases and controls from part 1 of the study that were registered in CPRD for a 18 
minimum of 5.5 years before their index date. Cases were matched to one control of the same age 19 
and sex. Where there was more than one potential match the control was selected at random. Cases 20 
who could not be matched to a control with follow-up covering the 5.5 years before their index date 21 
were excluded from the study (Appendix A – Selection of cases and controls).  22 
Exposure to Depression  23 
We defined exposure to depression as prevalent depression five years (4.5-5.5 years, Appendix B) 24 
prior to the index date. We defined prevalent depression as any individual with a code for a diagnosis 25 
or symptoms of depression in that year, or a prescription for antidepressant medication in that year 26 
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and a previous code for depression in their clinical record (Appendix C – code list).22,26 An initial analysis 1 
revealed amitriptyline was used at a dose of 30mg or less per day in a large majority, below the dose 2 
recommended for the treatment of depression, we therefore excluded tricyclic antidepressants from 3 
the analysis.27 We included codes for depressive symptoms, as well as diagnostic codes for depression, 4 
since this has been shown to improve accuracy of depression estimation compared with the use of 5 
diagnostic depression codes alone and accounts for a shift in temporal trends in coding for 6 
depression.28,29  7 
Since some individuals report GI symptoms many years before IBD is diagnosed,13 some cases of 8 
depression could develop after the onset of IBD-associated GI symptoms, but before their diagnosis.16 9 
We therefore created 2 sub-groups among individuals with prevalent depression: i) those who had 10 
already reported GI symptoms before the onset of their depression and ii) those who had not. We 11 
defined individuals as having reported GI symptoms before the onset of their depression if they had 12 
codes for relevant GI symptoms: abdominal pain, diarrhoea and per rectal bleeding (Appendix D), at 13 
any time before their first code for depression or antidepressant medication prescription.   14 
Covariates 15 
We adjusted for the covariates of smoking and socio-economic status. Smoking status has been linked 16 
to both depression and also the risk of developing IBD.30,31 We defined individuals as `smokers’, `ex-17 
smokers’ or `non-smokers’ based on codes for smoking status in the five years before the end of the 18 
exposure period (4.5 to 9.5 years before the index date). Individuals whose most recent code indicated 19 
active smoking were classed as `smokers’ and those with codes indicating previous but not current 20 
smoking were classed as `ex-smokers’. Individuals who had only `non-smoker’ codes were classified 21 
as `non-smokers’. Individuals without data on smoking have been shown to likely be either never-22 
smokers or non-recent smokers and were therefore classed as `non-smokers’.32 We used the Index of 23 
Multiple Deprivation (IMD), a postcode-linked measure of socio-economic deprivation, to assign 24 
individuals to 1 of 5 groups using IMD quintiles, from IMD group 1 (least deprived) to 5 (most 25 
deprived).   26 
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Statistical Analysis 1 
We used conditional logistic regression to calculate odds ratios (OR) and 95% confidence intervals for 2 
the risk of CD and UC according to depression status. All models were conditional on matching of age 3 
and sex.  4 
We assigned patients with depression 4.5-5.5 years before the index date to 2 sub-groups, i) those 5 
who had already reported GI symptoms before the onset of their depression and ii) those who had 6 
not. 7 
Model 1: We calculated the risk of CD and UC in the two sub-groups relative to individuals without 8 
depression.  9 
Model 2: We calculated the risk of CD and UC in the two sub-groups described above relative to 10 
individuals without depression, adjusting for smoking and socio-economic status. In a sensitivity 11 
analysis we replicated model 2 but altered the exposure period for depression to between two and 12 
four years prior to the index date. 13 
Model 3: Since coding for depression and depressive symptoms may underestimate the prevalence of 14 
depression, and a tenth of our study sample were prescribed antidepressant medication without a 15 
code for depression (Figure 1), we conducted a further analysis,  adjusting for smoking and socio-16 
economic status but applying a broader definition of prevalent depression. In this model individuals 17 
with antidepressant medication prescriptions but no code for depression or depressive symptoms 18 
were also categorised as having prevalent depression.  19 
All analyses were performed using STATA 16 (Statacorp LP, USA). 20 
  21 
Depression in individuals who subsequently develop Inflammatory Bowel Disease: a population-
based nested case-control study 
11 
 
Results 1 
 2 
Between 1st January 1998 and 1st May 2016, we identified 5,874 incident cases of CD, 13,681 incident 3 
cases of UC and two control groups of 23,496 and 54,724 individuals without IBD respectively. Median 4 
follow-back before the diagnosis date was 7.4 years.  5 
Depression before the diagnosis of IBD – Study Part 1 6 
 7 
The prevalence of depression in cases who developed UC and CD was similar to that of the control 8 
groups 10 years before diagnosis (cases vs. controls UC: 1.7% vs. 1.5%, CD: 1.7% vs. 1.6%).  9 
However, as early as nine years before diagnosis, UC cases had a higher prevalence of depression 10 
compared with the control group, increasing to 5.9% of UC cases vs. 4.7% of controls in the year before 11 
diagnosis (Risk difference: 1.2%, 95% CI 0.7%-1.7%). In CD, a similar divergence was seen from seven 12 
years before diagnosis, eventually increasing to 6.1% of CD cases having prevalent depression 13 
compared with 4.5% of controls in the year before diagnosis (Risk difference: 1.6%, 95% CI 0.8%-2.3%, 14 
see Figure 2 and Appendix E). 15 
Prior depression and the risk of ulcerative colitis and Crohn’s Disease – Study Part 2 16 
 17 
We identified 10,829 cases of UC and 4531 cases of CD with follow-up covering the exposure period 5 18 
years (4.5 – 5.5 years) before their diagnosis date and matched 1:1 to controls without IBD. Cases of 19 
UC and CD were more likely to have prevalent depression during the exposure period than their 20 
respective control groups (Table 1).  21 
Model 1: Relative to those without depression, individuals with depression alone had an increased 22 
risk of developing UC (OR 1.25, 95%CI 1.03-1.52). We found a similar pattern for CD (OR 1.21, 95%CI 23 
0.90-1.63). The risk estimates were higher for those with depression and previous GI symptoms (UC: 24 
OR 1.58, 95%CI 1.24-2.02; CD: OR 1.36, 95%CI 0.94-1.99, Appendix F). 25 
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Model 2: After additionally adjusting for smoking status and socio-economic status, individuals with 1 
depression alone had a similar risk of developing UC and CD relative to those without depression (UC: 2 
OR 1.21, 95% CI 0.99-1.47, CD: OR 1.05, 95% CI 0.78-1.42). The risk estimates were higher for those 3 
with depression and previous GI symptoms (UC: OR 1.52, 95% CI 1.19-1.94, CD: OR 1.21, 95% CI 0.82-4 
1.77, Table 2).  5 
A sensitivity analysis replicated model 2 but changed the exposure period for depression to between 6 
two and four years prior to the index date. Individuals with depression alone had an increased risk of 7 
developing UC but not CD relative to those without depression (UC: OR 1.23, 95% CI 1.05-1.45, CD: OR 8 
1.08, 95% CI 0.84-1.39). Individuals with depression and previous GI symptoms had higher risk 9 
estimates for developing UC and CD (UC: OR 1.29, 95% CI 1.08-1.53, CD: OR 1.29, 95% CI 0.98-1.71). 10 
Model 3: Using a broader definition of prevalent depression to account for under reporting in primary 11 
care we found, after adjustment for all covariates, individuals with depression alone without prior GI 12 
symptoms,  had a similar risk of UC and CD compared with individuals without depression (UC: OR 13 
1.13, 95% CI 0.99-1.29, CD: OR 1.12, 95% CI 0.91-1.38). Individuals with depression and previous GI 14 
symptoms were at increased risk of both UC and CD compared with those who were not depressed 15 
(UC: OR 1.47, 95% CI 1.21-1.79, CD: OR 1.41, 95% CI 1.04-1.92, Table 2).  16 
Discussion 17 
 18 
Main findings 19 
 20 
We found individuals with UC and CD had a higher prevalence of depression than their matched 21 
control groups in the years prior to IBD diagnosis. Depression rates diverged, as early as nine years 22 
before diagnosis, with the largest excess in the year before diagnosis. After adjusting for relevant 23 
covariates, individuals diagnosed with depression after already experiencing GI symptoms were at 24 
increased risk of later being diagnosed with UC and CD. However, depression alone was not associated 25 
with a future diagnosis of either UC or CD.  26 
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Findings in relation to previous studies 1 
We found individuals with IBD had an excess of prevalent depression five years before diagnosis 2 
relative to controls. This supports a recent study, using the Danish national registries, which 3 
demonstrated mood disorders as a whole, including depression and bipolar affective disorder, were 4 
associated with subsequent diagnoses of IBD.33 5 
However, after accounting for GI symptoms that pre-dated the onset of depression we found that 6 
depression alone was not associated with developing UC or CD. Our findings differ from two previous 7 
studies that attempted to account for diagnostic delay of IBD.34,35 Ananthakrishnan et al. (2013) found 8 
women with depressive symptoms were more likely to develop CD (HR 2.36, 1.40-3.99) but not UC 9 
(HR 1.14, 0.68-1.92).35 Frolkis et al. (2018) found individuals with depression were at increased risk of 10 
developing both CD (HR=2.11; 95% CI 1.65 to 2.70) and UC (HR 2.23, 95% CI 1.92 to 2.60).34 However, 11 
neither study was able to determine whether GI symptoms were already present before the onset of 12 
depression. This may have confounded their results as one in ten individuals with IBD present to their 13 
doctor with GI symptoms 5 years before diagnosis and these symptoms could lead to depression.36 14 
The importance of determining the temporality between the onset of depression and GI symptoms in 15 
establishing the associated risk of premorbid depression on subsequently developing IBD has been 16 
highlighted.16 To address this issue, we identified all individuals with depression 4.5-5.5 years before 17 
the index date who had previously visited their primary care physician for GI symptoms before the 18 
onset of their depression. We found these individuals were at increased risk of later being diagnosed 19 
with UC and CD but not those who had depression alone. We found similar results when a broader 20 
definition of depression was used to account for under-reporting of depression in primary care. We 21 
also carried out a sensitivity analysis using an exposure period closer to the index date, two to four 22 
years before IBD diagnosis, which indicated no increased risk in CD amongst individuals with 23 
depression alone and a small increase in the risk of UC. This contrasts with the findings of 24 
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Ananthakrishnan et al. (2013) who found an increased risk in CD but not UC using a similar time frame, 1 
though the reason for this difference is unclear.35 2 
Both depression and IBD often have a gradual and subtle onset making it difficult to determine which 3 
condition developed first. This may mean that, therefore, previously described associations between 4 
depression and subsequent IBD may, at least in part, be the consequence of reverse causation with 5 
undiagnosed GI symptoms of IBD resulting in depression. 6 
Strengths and Limitations 7 
To our knowledge this is the first population-based study to examine the association of premorbid 8 
depression with the later development of IBD while also accounting for pre-existing GI symptoms. 9 
Data were drawn from a large nationally representative validated research database, free of referral 10 
centre bias. Data were recorded at the time of consultation and are therefore not subject to recall 11 
bias.  12 
In common with all observational studies using routinely collected data, inaccuracies in coding and 13 
completeness may occur. Previous studies suggest up to 50% of depression is not detected in primary 14 
care.37 This may explain why the prevalence of depression in our study population was lower than in 15 
national surveys, however most missed cases of depression are mild.24,38 As with previous studies, we 16 
were unable to determine the severity of depression using a standardised psychiatric tool since these 17 
are not routinely used by UK primary care health professionals.34,39 While our findings suggest 18 
depression, in the absence of GI symptoms, is not associated with subsequent development of IBD, 19 
formal testing of directionality and causality between depression and IBD was not possible in this 20 
study. We acknowledge GI symptoms are not specific to IBD and may have been due to other 21 
conditions. We adjusted for socio-economic status, using the index of multiple deprivation data from 22 
2015, this is a cross-sectional marker of socio-economic status which we acknowledge is dynamic and 23 
may have changed during our study period. Finally, given cases were not matched to controls from 24 
the same primary care practice it is possible different practice patterns may have affected our results.  25 
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Implications 1 
Our findings suggest depression, in the absence of GI symptoms, is not associated with the subsequent 2 
development of either UC or CD. However, our findings of an excess of depression in the years before 3 
IBD diagnosis support a holistic approach when individuals present with GI symptoms, including 4 
screening for depression.  5 
We found individuals who experienced GI symptoms before the recorded onset of depression were at 6 
an increased risk of eventually receiving a diagnosis of IBD. This suggests depression may arise 7 
secondary to GI symptoms experienced during the period prior to the diagnosis of IBD. Our findings 8 
may relate to diagnostic delay in IBD and further research is needed to ascertain the burden of such 9 
delays and their relationship with other co-morbidities including poor mental health. 10 
Conclusions 11 
Individuals with UC and CD have a higher prevalence of depression than matched control groups in 12 
the years prior to IBD diagnosis. Depression rates diverge, as early as nine years before diagnosis, with 13 
the largest excess in the year before diagnosis. Depression, in the absence of prior GI symptoms, is 14 
not associated with subsequent development of IBD. However, depression with GI symptoms should 15 
prompt investigation for IBD. 16 
 17 
  18 
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Table 1: Baseline characteristics of cases and controls in study part 2 1 
IBD Status Crohn’s Disease  Control Group 
(CD) 
Ulcerative Colitis Control Group 
(UC) 
n= 4,531 4,531 10,829 10,829 
Demographics     
Male (%) 
 
Age at diagnosis (%) 
2,137  (47) 
 
2,137  (47) 5,832  (54) 5,832  (54) 
<17 
17-39 
>39 
406    (8) 
1,640  (36) 
2,485  (55) 
406    (8) 
1,640  (36) 
2,485  (55) 
266    (2) 
2,812  (26) 
7,751  (72) 
266    (2) 
2,812  (26) 
7,751  (72) 
 
Social deprivation (%) 
IMD 1-3 
IMD 4-5 
Unknown 
 
1,632  (36) 
957  (21) 
1,942  (43) 
 
1,674  (37) 
871  (19) 
1,986  (44) 
 
4,428  (41) 
1,868  (17) 
4,533  (42) 
 
4,135  (38) 
 2,071  (19) 
4,623  (43) 
Smoking Status (%) 
Non Smoker 
Smoker  
Ex-Smoker 
 
3,413  (75) 
644  (14) 
474  (10) 
 
 
3,769  (83) 
440  (10) 
322    (7) 
 
8,063  (74) 
1,142  (11) 
1,624  (15) 
 
8,581  (79) 
1,073  (10) 
1,175  (11) 
Depression Status (%) 
No Depression 
Depression Alone 
Depression & GI symptoms 
 
4,365  (96) 
101 (2.2) 
65 (1.4) 
 
 4,399  (97) 
84 (1.9) 
48 (1.1) 
 
10,431  (96) 
230 (2.1) 
168 (1.6) 
 
10,533  (97) 
188 (1.7) 
108 (1.0) 
     
Smoking and depression status refer to the period 5 years before the index date  2 
IMD – Index of Multiple Deprivation. IMD 1 represents the least deprived and IMD 5 the most deprived. Index of multiple 3 
deprivation data are available only in England. 4 
 5 
 6 
 7 
 8 
9 
Depression in individuals who subsequently develop Inflammatory Bowel Disease: a population-
based nested case-control study 
17 
 
Table 2: Risk of Crohn’s Disease and ulcerative colitis by depression status 1 
 2 
  Crohn's Disease Ulcerative colitis 
Conditional Logistic 
Regression 
Model 2 Model 3 Model 2 Model 3 
n=9,062 n=9,062 n=21,658 n=21,658 
            
 OR 95% CI OR 95% CI OR 95% CI OR 95% CI 
Depression Status         
No Depression  1  -  1  -  1  -  1  -  
Depression Alone  1.05  0.78-1.42  1.12  0.91-1.38  1.21  0.99-1.47  1.13  0.99-1.29  
Depression with 
previous GI symptoms 
1.21 0.82-1.77 1.41 1.04-1.92 1.52 1.19-1.94 1.47 1.21-1.79 
         
Smoking Status         
Non-Smoker 1 - 1 - 1 - 1 - 
Smoker 1.67 1.46-1.91 1.65 1.44-1.89 1.13 1.04-1.24 1.14 1.04-1.25 
Ex-Smoker 1.69 1.44-1.97 1.68 1.44-1.96 1.48 1.36-1.61 1.49 1.37-1.61 
         
Social deprivation (%)         
IMD 1-3 1 - 1 - 1 - 1 - 
IMD 4-5 1.08 0.96-1.21 1.08 0.96-1.21 0.83 0.77-0.90 0.83 0.77-0.90 
Unknown 1.03 0.90-1.08 0.99 0.90-1.09 0.91 0.86-0.97 0.91 0.86-0.97 
         
 3 
 4 
Cases and controls were matched by age and sex and therefore conditional logistic regression was used. 5 
Statistically significant results highlighted in bold. 6 
 7 
Model 2 - We calculated the risk of CD or UC adjusting for all variables in the table conditional on matching for 8 
age and sex. 9 
Model 3 - We calculated the risk of CD or UC adjusting for all variables in the table conditional on matching for 10 
age and sex. In this model individuals with antidepressant medication prescriptions but no code for depression 11 
or depressive symptoms were also categorised as having prevalent depression. 12 
No Depression - No depression in the exposure period 13 
Depression Alone -   Prevalent depression in the exposure period but no gastrointestinal symptoms preceding 14 
the onset of depression 15 
Depression with previous GI symptoms – Prevalent depression in the exposure period with gastrointestinal 16 
symptoms preceding the onset of depression 17 
IMD – Index of Multiple Deprivation, 1 represents the least deprived and 5 represents the most deprived. 18 
Index of multiple deprivation data are only available in England. 19 
  20 
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